← Back to Search

HEART Camp for Heart Failure

N/A
Recruiting
Led By Windy W Alonso, PhD
Research Sponsored by University of Nebraska
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of heart failure with an ejection fraction greater than or equal to 50
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights

Study Summary

This trial aims to understand how meeting with a coach, either in person or through videoconferencing, can benefit patients with heart failure and difficulty exercising. Participants will be divided into three groups and will

Who is the study for?
This trial is for adults with a type of heart failure where the heart muscle pumps normally but is stiff (HFpEF). They must have been diagnosed via echocardiogram in the last 2 years, be on stable heart medication for at least a month, and meet certain criteria or show evidence of HFpEF.Check my eligibility
What is being tested?
The study tests if coaching helps patients with HFpEF exercise more. It compares three groups: one gets usual care, another adds in-person coaching, and the third has virtual coaching. All participants receive fitness center access, a watch, and a heart rate monitor to use during exercise.See study design
What are the potential side effects?
Since this trial focuses on exercise intervention rather than medication, side effects may include typical exercise-related issues such as muscle soreness or strain. However specific side effects will depend on individual health conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My heart pumps blood well, with an ejection fraction of 50% or more.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Exercise Adherence
Secondary outcome measures
C-reactive protein
C-reactive protein (CRP)
Dyspnea Severity
+13 more
Other outcome measures
Attitudes toward exercise
Cognitive Assessment
Emotional Support
+8 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: HEART Camp ConnectExperimental Treatment1 Intervention
Participants in the HEART Camp Connect group will be provided paid, virtual access to the medical fitness center and virtual coaching by a trained coach via videoconference. Participants will also receive automated, asynchronous motivational electronic messaging if they are below the weekly adherence threshold.
Group II: HEART CampExperimental Treatment1 Intervention
Participants in the HEART Camp group will be provided paid, in-person access to the medical fitness center and in-person coaching by a trained coach.
Group III: Enhanced Usual CareActive Control1 Intervention
Participants in the Enhanced Usual Care group will be provided paid virtual access to the medical fitness center and virtual availability of the medical fitness center staff and study personnel for participant-initiated questions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HEART Camp Connect
2022
N/A
~20

Find a Location

Who is running the clinical trial?

University of NebraskaLead Sponsor
539 Previous Clinical Trials
1,144,434 Total Patients Enrolled
12 Trials studying Heart Failure
740 Patients Enrolled for Heart Failure
Windy W Alonso, PhDPrincipal InvestigatorUniversity of Nebraska

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the number of participants currently involved in this clinical investigation?

"Indeed, the information available on clinicaltrials.gov confirms that this particular clinical trial is presently seeking eligible participants. The study was initially posted on November 6th, 2023 and most recently updated on January 4th, 2024. A total of 300 patients will be enrolled at a single research site."

Answered by AI

Are there any ongoing efforts to enroll participants in this clinical trial at the moment?

"Indeed, the information provided on clinicaltrials.gov confirms that this particular clinical trial is actively seeking individuals to participate. The trial was initially posted on November 6, 2023, and most recently updated on January 4, 2024. In total, they aim to recruit 300 patients from a single location."

Answered by AI
~200 spots leftby Sep 2027